RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

Children with spinal muscular atrophy (SMA) experience benefits from receiving a disease-modifying gene therapy, but many ...

To address the unmet need for a cure for RTT, the therapeutic potential of adult Neural Precursor Cells (NPCs) was ...

By tracking the changes in prostate cancer cells over time, researchers at the Johns Hopkins Kimmel Cancer Center have found that activation of the MYC gene -; a well-known cancer-causing gene -; sets ...

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

An innovative approach to healthcare, precision medicine is a new medical model that takes into account individual ...

The new company focuses on producing components needed to manufacture RNA-based therapies for which there is increasing ...

DNA (pDNA) purification system. PlasmidPro enables innovation at scale, providing complete automation across mini and maxi ...

In the meantime current gene therapies remain expensive and challenging to scale up because each patient’s batch of cells has ...

Novo Nordisk isn’t done with the RNA deals, this time penning a $530 million biobucks deal to work with Korro Bio on two ...

Analyst Thomas Smith of Leerink Partners maintained a Buy rating on Cartesian Therapeutics (RNAC – Research Report), retaining the price ...